ThermoGenesis Holdings, Inc. (THMO)

ThermoGenesis Holdings Announces Financial Results for the First Quarter Ended March 31, 2022 and Provides Corporate Update

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the first quarter ended March 31, 2022 and provided a corporate strategic update.

• 
  Amcomri Reports Increase in Revenues, Gross Margin and Net Income for the First Quarter of Fiscal 2022

  GlobeNewswire
• 
  DIGITAL ALLY, INC ANNOUNCES FIRST QUARTER 2022 OPERATING RESULTS

  GlobeNewswire

ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide a Corporate Strategic Update

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the first quarter ended March 31, 2022 and provide a corporate strategic update on Thursday, May 19, 2022, after the close of trading. A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET.

• 
  Partners Value Investments L.P. Announces 2022 First Quarter Results

  GlobeNewswire
• BIMI International Medical Announces First Quarter 2022 Financial Results

  GlobeNewswire

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) About To Shift From Loss To Profit

We feel now is a pretty good time to analyse ThermoGenesis Holdings, Inc.'s ( NASDAQ:THMO ) business as it appears the...